• 제목/요약/키워드: metabolizing enzymes

검색결과 201건 처리시간 0.027초

간장장해와 Ketosis시에 Cytochrome P450IIE의 Regulatory Mechanism에 관한 연구 (Regulatory Mechanism of Cytochrome P450IIE in the Rat with Hepatic Injury and Ketosis)

  • 윤여표;강원식;이세창;손동환
    • 한국환경보건학회지
    • /
    • 제19권3호
    • /
    • pp.58-63
    • /
    • 1993
  • In order to elucidate the alteration of drug-metabolizing enzymes and mechanism in the animal with hepatic injury and ketosis, the regulation of P450IIE was studied in the rats with heaptic injury caused by CCl$_4$ and with ketosis caused by streptozotocin and high-fat diet. P450IIE expression in liver was examined by the combination of enzyme activities, Western immunoblot, and mRNA Northern blot analyses using specific polyclonal antibody and cDNA probe for P450IIE. Enzyme activity and amounts of immunoreactive P450IIE were rapidly decreased in a time-dependent manner after a single dose of CCl$_4$ . However, the decreases in P450IIE enzyme activity and immunoreactive protein by CCl$_4$ were not accompanied by a decline in its mRNA level. The data thus suggested a post-translational reduction of P450IIE by CCl$_4$. The enzyme activities (aniline hydroxylase) in hepatic microsomes were elevated about 2-3-fold by streptozotocin and feeding with a high fat diet. This increases in enzyme activities were also accompanied by 3-fold increases in immunoreactive P450IIE protein and its mRNA. Our data thus indicated that P450IIE induction during the ketosis appears to be due to pretranslational activation.

  • PDF

RIP3-Dependent Accumulation of Mitochondrial Superoxide Anions in TNF-α-Induced Necroptosis

  • Lee, Jiyoung;Lee, Sunmi;Min, Seongchun;Kang, Sang Won
    • Molecules and Cells
    • /
    • 제45권4호
    • /
    • pp.193-201
    • /
    • 2022
  • Excessive production of reactive oxygen species (ROS) is a key phenomenon in tumor necrosis factor (TNF)-α-induced cell death. However, the role of ROS in necroptosis remains mostly elusive. In this study, we show that TNF-α induces the mitochondrial accumulation of superoxide anions, not H2O2, in cancer cells undergoing necroptosis. TNF-α-induced mitochondrial superoxide anions production is strictly RIP3 expression-dependent. Unexpectedly, TNF-α stimulates NADPH oxidase (NOX), not mitochondrial energy metabolism, to activate superoxide production in the RIP3-positive cancer cells. In parallel, mitochondrial superoxide-metabolizing enzymes, such as manganese-superoxide dismutase (SOD2) and peroxiredoxin III, are not involved in the superoxide accumulation. Mitochondrial-targeted superoxide scavengers and a NOX inhibitor eliminate the accumulated superoxide without affecting TNF-α-induced necroptosis. Therefore, our study provides the first evidence that mitochondrial superoxide accumulation is a consequence of necroptosis.

Flavonoids Biotransformation by Human Gut Bacterium Dorea sp. MRG-IFC3 Cell-Free Extract

  • Huynh Thi Ngoc Mi;Heji Kim;Jong Suk Lee;Bekir Engin Eser;Jaehong Han
    • Journal of Microbiology and Biotechnology
    • /
    • 제34권6호
    • /
    • pp.1270-1275
    • /
    • 2024
  • Human gut bacterium Dorea sp. MRG-IFC3 is unique in that it is capable of metabolizing puerarin, an isoflavone C-glycoside, whereas it shows broad substrate glycosidase activity for the various flavonoid O-glycosides. To address the question on the substrate specificity, as well as biochemical characteristics, cell-free biotransformation of flavonoid glycosides was performed under various conditions. The results showed that there are two different enzyme systems responsible for the metabolism of flavonoid C-glycosides and O-glycosides in the MRG-IFC3 strain. The system responsible for the conversion of puerarin was inducible and comprised of two enzymes. One enzyme oxidizes puerarin to 3"-oxo-puerarin and the other enzyme converts 3"-oxo-puearin to daidzein. The second enzyme was only active toward 3"-oxo-puerarin. The activity of puerarin conversion to daidzein was enhanced in the presence of Mn2+ and NAD+. It was concluded that the puerarin C-deglycosylation by Dorea sp. MRG-IFC3 possibly adopts the same biochemical mechanism as the strain PUE, a species of Dorea longicatena.

낙동강 하구에서 채집한 문절망둑 Acanthogobius flavimanus의 간장 약물대사효소계와 성호르몬 농도 (Responses in Hepatic Xenobiotic Metabolizing Enzymes and Sex Hormones of Yellowfin Goby Acanthogobius flavimanus in Nakdong Estuary)

  • 이지선;정지현;한창희;심원준;전중균
    • 환경생물
    • /
    • 제26권2호
    • /
    • pp.87-93
    • /
    • 2008
  • 낙동강 상류로부터 유입되는 각종 오염물질로 심하게 오염된 낙동강 하구역에서 오염정도가 다른 두 지역으로부터 문절망둑 Acanthogobius flavimanus을 채집하여 이들의 간중량지수(HSI), 생식선중량지수(GSI), 해독효소계 및 성 호르몬 수준을 비교하였다. 해독효소계로는 cytochrome P450 (CYP), NADPH-cytochrome P450 reductase (P450R), NADH-cytochrome b5 reductase (b5R), ethokyresorufin deethylase (EROD), glutathione S-transferase (GST)를 조사하였고, 성 호르몬으로는 자성호르몬인 17$\beta$-estradio(E2)을 비롯하여 웅성호르몬인 testosterone (TT), 11-ketotestolterone (11-KT)을 측정하였다. 그 결과, HSI는 site 1에서 잡은 것이 암수 모두 유의적으로 컸고, GSI는 site 1의 암컷에서 유의적으로 작았다. 그리고 성호르몬 중 11-KT과 TT농도는 오염지역에 따라 차이를 보이지 않았지만, E2농도는 site 1에서 유의적으로 높았다(p<0.05).그리고 해독효소계의 수준은 site 1의 것이 CYP와 EROD수준은 유의적으로 낮았던 반면에 P450R, b5R 및 GST 활성은 site 1에서 높았다. 이들 결과를 정리하면, 낙동강 하구에 서식하는 문절망둑은 성 호르몬 대사를 교란시키는 화합물에 의해 영향을 받고 있으며, 특히 암컷이 더욱 크게 받는다는 것을 확인할 수 있었다.

2-Methyl-4-(phenyldiazenyl)phenyl picolinamide의 o-toluidinyl 구조가 AHR 길항저해 활성에 미치는 영향 (The Impact of o-Toluidinyl Structure of 2-Methyl-4-(2-methylphenyldiazenyl)phenyl picolinamide on the AHR Antagonistic Activity)

  • 이효성
    • 한국융합학회논문지
    • /
    • 제8권1호
    • /
    • pp.115-121
    • /
    • 2017
  • AHR(Aryl Hydrocarbon Receptor, 방향성탄화수소 수용체)은 리간드에 의해 활성화되어 체내 외래물질의 대사를 조절하는 전사인자다. 생체 내에서 AHR의 생리학적 역할은 오랜 기간 연구되어 왔으나 antagonist를 비롯한 적절한 화학적 도구의 부재로 그 역할 규명이 제한되어 있다. AHR이 암을 비롯한 여러 질병의 발병기전에 관여되어 있다는 것이 밝혀짐에 따라 유효한 약물 표적으로 간주되나 화학적 도구의 부재로 인해 치료용 약물 개발 역시 제한되어 있다. 기존 antagonist 들은 저농도에서는 활성이 있으나 높은 농도에서는 AHR의 활성화를 유도하는 부분적 antagonist이므로 순수 저해활성을 가지는 신규 antagonist의 개발이 필요하다. 본 연구에서는 2-methyl-4-(2-methylphenyldiazenyl)phenyl picolinamide의 o-toluidinyl 고리구조의 변경하여 활성을 평가하는 유기화학과 분자생물학의 융합연구를 통하여 o-toluidinyl 구조를 최적화하였다.

Effects of Baicalin on Oral Pharmacokinetics of Caffeine in Rats

  • Noh, Keumhan;Nepal, Mahesh Raj;Jeong, Ki Sun;Kim, Sun-A;Um, Yeon Ji;Seo, Chae Shin;Kang, Mi Jeong;Park, Pil-Hoon;Kang, Wonku;Jeong, Hye Gwang;Jeong, Tae Cheon
    • Biomolecules & Therapeutics
    • /
    • 제23권2호
    • /
    • pp.201-206
    • /
    • 2015
  • Scutellaria baicalensis is one of the most widely used herbal medicines in East Asia. Because baicalein and baicalin are major components of this herb, it is important to understand the effects of these compounds on drug metabolizing enzymes, such as cytochrome P450 (CYP), for evaluating herb-drug interaction. The effects of baicalin and baicalein on activities of ethoxyresorufin O-deethylase (EROD), methoxyresorufin O-demethylase (MROD), benzyloxyresorufin O-debenzylase (BROD), p-nitrophenol hydroxylase and erythromycin N-demethylase were assessed in rat liver microsomes in the present study. In addition, the pharmacokinetics of caffeine and its three metabolites (i.e., paraxanthine, theobromine and theophylline) in baicalin-treated rats were compared with untreated control. As results, EROD, MROD and BROD activities were inhibited by both baicalin and baicalein. However, there were no significant differences in the pharmacokinetic parameters of oral caffeine and its three metabolites between control and baicalin-treated rats. When the plasma concentration of baicalin was determined, the maximum concentration of baicalin was below the estimated $IC_{50}$ values observed in vitro. In conclusion, baicalin had no effects on the pharmacokinetics of caffeine and its metabolites in vivo, following single oral administration in rats.

Enhanced Activity of Flavin-containing Monooxygenase in Human Subjects with High Body Mass Index and in Obese Mice Fed a High-fat Diet

  • Ko, Jeong-Hyeon;Lee, Tong-Joo;Park, Chang-Shin;Jang, Eun-Hee;Oh, Yun-Mi;Kang, Ju-Hee
    • Molecular & Cellular Toxicology
    • /
    • 제4권1호
    • /
    • pp.5-10
    • /
    • 2008
  • The effect of obesity on the drug-metabolizing enzymes remains an important issue for clinician since obesity is a world wide epidemic problem. However, little is known about the effects of obesity on flavincontaining monooxygenase (FMO) production and activity. We show here for the first time that in vivo FMO activity determined by urinary ranitidine (RA) metabolites ratio in human, was higher in subjects with a high body mass index (BMI, kg/$m^2$, 21.97-30.32) than in those with an intermediate BMI (range 19.38-21.83). Moreover, there was a significant correlation between FMO activity and BMI in 209 subjects. In high fat diet-induced obese mice, we also observed that the hepatic expression of FMO (225% of lean mice) and the activity measured by the RA Noxidation rate ($513{\pm}58.1$ vs. $349{\pm}66.0$ pmol/hr per mg protein) were significantly higher than in lean mice fed a control diet. Unknown factors rather than leptin or insulin appeared to regulate the hepatic FMO production. Thus, FMO activity may be increased in obese or overweight individuals. Moreover, the regulation of FMO activity in subjects with morbid obesity, with or without complications and its clinical implications, should be investigated further.

의약품에서의 성별차이 및 유발요인 (Review of Gender Differences in Medicine and Primary Factors Resulting in Gender Differences)

  • 김현주;최종민;김유진;채송화;박정현;오지현;김경희;허정선;곽혜선;이화정
    • 한국임상약학회지
    • /
    • 제20권2호
    • /
    • pp.128-137
    • /
    • 2010
  • This review summarizes gender differences in pharmacokinetics, pharmacodynamics, and adverse drug reactions. Gender differences in pharmacokinetics are categorized by four major factors: absorption/bioavailability, distribution, metabolism, and elimination. There are sex-based differences in gastric emptying time, gastric alcohol dehydrogenase activity, apparent volume of distribution, ${\alpha}1$-acid glycoprotein level, phase I (CYP) and phase II metabolizing enzymes, glomerular filtration rate, and drug transporters. This review also reports gender differences in pharmacokinetics and pharmacodynamics of cardiovascular agents, central nervous system acting agents and antiviral agents. In addition, it has been reported that females experience more adverse reactions such as coughing, tachycardia, nausea, vomiting, rash, hypersensitivity, hepatotoxicity, and metabolic disorder after taking cardiovascular, central nervous system acting and antiviral agents. Therefore, in order to provide optimal drug dosage regimens both in male and female, gender differences in pharmacokinetics, pharmacodynamics, and adverse drug reactions must be considered.

Interethnic Variations of CYP2C19 Genetic Polymorphism

  • Tassaneeyakul, Wongwiwat;Tassaneeyakul, Wichittra
    • Toxicological Research
    • /
    • 제17권
    • /
    • pp.145-155
    • /
    • 2001
  • Cytochrome P4502C19 (CYP2C19) is one of human polymorphic xenobiotic-metabolizing enzymes. The enzyme has been reported to catalyze more than 70 substrates, involving more than 100 reactions. These include several classes of therapeutic agents (e.g. anti-microbial. cardiovascular, psycho-active, etc.), sex hormones and insecticides. Associations of the CYP2C19 genotype/phenotype with individual differences in drug efficacy (e.g. diazepam, omeprazole, proguanil) and toxicity (e.g. mephenytoin, barbiturates) have been documented by many investigators. At least 11 allelic variants of CYP2C19 gene were reported to date. Most of the mutant alleles found in the poor metabolizer (PM) led to the production of truncated and/or inactive proteins. Except for the exon 6, single-nucleotide mutations were reported in all nine exons of the gene. Genetic polymorphism of CYP2C19 shows marked interethnic variation with the population frequencies of PM phenotype ranging from 1∼2% up to more than 50%. The prevalence of CYP2C19 PM tends to be higher in Asian and certain Pacific Islanders than other race or ethnic specificity. Genotyping results of CYP2C19 also revealed that there are different proportions of individual mutant alleles among ethnic populations. This may, in part, explains the interethnic difference in the metabolism of certain drugs (i.e. diazepam), though they were from the same CYP2C19 phenotype. Recently, our research group has studied the genotype and phenotype of CYP2C19 and found that the PM frequency (7∼8%) in Thais is lower than other Asian populations. Molecular and clinical impacts of this finding warrant to further investigation.

  • PDF

Predictive Potential of Glutathione S-Transferase Polymorphisms for Prognosis of Osteosarcoma Patients on Chemotherapy

  • Zhang, Shai-Lin;Mao, Ning-Fang;Sun, Jun-Ying;Shi, Zhi-Cai;Wang, Bing;Sun, Yong-Jian
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권6호
    • /
    • pp.2705-2709
    • /
    • 2012
  • Objective: To evaluate the predictive value of glutathione S-transferase (GST) gene polymorphisms for the prognosis of osteosarcoma patients receiving chemotherapy. Methods: A total of 159 patients were included in our study between January 2005 and December 2007., with follow-up until January 2012. Genotyping was based upon the duplex polymerase-chain-reaction with the PCR-CTPP method. Results: At the time of diagnosis, 15.4% of the patients presented with metastasis, while 22.3% developed metastasis during follow-up. At the time of final analysis on January 2012, the median follow-up was 45.5 months. Patients with null GSTM1 and GSTT1 had a higher event free survival rate than non-null genotype, but no significant association was found between the two genotypes and prognosis of osteosarcoma. Individuals with GSTP1 Val/Val genotype tended to live shorter than with the IIe/IIe genotype, and we found a significantly higher risk of death from osteosarcoma (adjusted HR=2.35, 95% CI=1.13-4.85). Conclusion: The GSTP1 gene polymorphism may have an important role in the prognosis of osteosarcoma patients with chemotherapy. Further analyses with larger samples and more genes encoding metabolizing and DNA repair enzymes are warranted.